Month: December 2020

Themis Acquired by Merck

Milestone Reflects Merck’s Commitment to Accelerate SARS-CoV-2 Vaccine Program KENILWORTH, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside the United States and Canada, today

Read More »
Close Menu